Lack of Effect in Desensitization With Intravenous Immunoglobulin and Rituximab in Highly Sensitized Patients

201275 citationsJournal Article

Authors

Kwaku Marfo

Ming Ling

Javier Chapochnick-Friedman

Daniel Glicklich · Montefiore Medical Center

Graciela de Boccardo · Montefiore Medical Center

Milan Kinkhabwala

Abstract

These results suggested that pretransplant desensitization with IVIG and rituximab was not successful in highly sensitized kidney transplant candidates with cPRA levels higher than 90%.

Topics & Keywords

Renal Transplantation Outcomes and Treatments Drug-Induced Adverse Reactions Immunodeficiency and Autoimmune Disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Transplantation

Volume 94, Issue 4, pp. 345-351

DOI: 10.1097/tp.0b013e3182590d2e

Field-Weighted Citation Impact: 6.86